These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38659102)

  • 1. Frequency of red blood cell phenotypes from genotyped Australian blood donors.
    Jacko G; Powley T; Daly J
    Transfus Med; 2024 Jun; 34(3):219-222. PubMed ID: 38659102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of red cell genotyping into the blood supply chain: a population-based study.
    Flegel WA; Gottschall JL; Denomme GA
    Lancet Haematol; 2015 Jul; 2(7):e282-9. PubMed ID: 26207259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass-scale donor red cell genotyping using real-time array technology.
    Denomme GA; Schanen MJ
    Immunohematology; 2015; 31(2):69-74. PubMed ID: 26495892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Genotyping on Selection of Red Blood Cell Donors for Transfusion.
    Jackups R
    Hematol Oncol Clin North Am; 2019 Oct; 33(5):813-823. PubMed ID: 31466606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood group genotyping: from patient to high-throughput donor screening.
    Veldhuisen B; van der Schoot CE; de Haas M
    Vox Sang; 2009 Oct; 97(3):198-206. PubMed ID: 19548962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing mass-scale red cell genotyping at a blood center.
    Flegel WA; Gottschall JL; Denomme GA
    Transfusion; 2015 Nov; 55(11):2610-5; quiz 2609. PubMed ID: 26094790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass-scale red cell genotyping of blood donors: from data visualization to historical antigen labeling and donor recruitment.
    Denomme GA; Anani WQ
    Transfusion; 2019 Sep; 59(9):2768-2770. PubMed ID: 31246285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass-scale red cell genotyping of blood donors.
    Denomme GA; Johnson ST; Pietz BC
    Transfus Apher Sci; 2011 Feb; 44(1):93-9. PubMed ID: 21292556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The screening of rare blood donors in a highly admixed population: A new approach for Holley and Diego genotyping and impact of genomic and self-reported ancestry.
    Muniz AA; da Silva AR; Ferraz IA; Martins ML; Godin MM; Schmidt LC; Dusse LMSA; da Silva Malta MCF
    Transfus Med; 2020 Apr; 30(2):148-156. PubMed ID: 31820508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of KEL*01 and KEL*02 Genotyping to Recruit Uncommon, Kell-positive, Reagent Red Cells Among Thai Blood Donors.
    Intharanut K; Khantisitthiporn O; Kupatawintu P; Leetrakool N; Mitundee S; Nathalang O
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for the provision of genotyped blood for transfusion.
    Denomme GA
    Br J Haematol; 2013 Oct; 163(1):3-9. PubMed ID: 23889672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature.
    Akinbolaji TJ
    Immunohematology; 2024 Jun; 40(2):58-64. PubMed ID: 38910442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Lombardy Rare Donor Programme.
    Revelli N; Villa MA; Paccapelo C; Manera MC; Rebulla P; Migliaccio AR; Marconi M;
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s249-55. PubMed ID: 23522888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEA BeadChip™ technology in immunohematology.
    Paccapelo C; Truglio F; Antonietta Villa M; Revelli N; Marconi M
    Immunohematology; 2015; 31(2):81-90. PubMed ID: 26495894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood group genotyping of blood donors: validation of a highly accurate routine method.
    Krog GR; Rieneck K; Clausen FB; Steffensen R; Dziegiel MH
    Transfusion; 2019 Oct; 59(10):3264-3274. PubMed ID: 31415105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular blood grouping of donors.
    St-Louis M
    Transfus Apher Sci; 2014 Apr; 50(2):175-82. PubMed ID: 24656492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte genotyping for transfusion-dependent patients at the Azienda Universitaria Policlinico of Naples.
    Belsito A; Costa D; Fiorito C; De Iorio G; Casamassimi A; Perrotta S; Napoli C
    Transfus Apher Sci; 2015 Feb; 52(1):72-7. PubMed ID: 25582271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operational issues for implementation of donor genotyping for red blood cell antigens.
    Nance ST
    Transfusion; 2007 Jul; 47(1 Suppl):69S-72S. PubMed ID: 17593290
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of selective phenotyping and genotyping to identify rare blood donors in Canada.
    Tordon B; Montemayor C; Clarke G; O'Brien SF; Goldman M
    Vox Sang; 2023 May; 118(5):398-401. PubMed ID: 36896484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-Mur screening and Mur antigen genotyping of voluntary blood donors in Guangzhou].
    Wei L; Ji Y; Mo C; Zhang R; Zhao Y; Luo H; Wang Z; Luo G
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Dec; 32(12):1833-5. PubMed ID: 23268422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.